Edition:
United States

Rui Kang Pharmaceutical Group Investments Ltd (8037.HK)

8037.HK on Hong Kong Stock

0.51HKD
3:37am EDT
Change (% chg)

HK$0.02 (+4.08%)
Prev Close
HK$0.49
Open
HK$0.52
Day's High
HK$0.53
Day's Low
HK$0.51
Volume
1,620,000
Avg. Vol
3,834,725
52-wk High
HK$0.68
52-wk Low
HK$0.16

Latest Key Developments (Source: Significant Developments)

Rui Kang Pharmaceutical enters into disposal agreement
Friday, 12 May 2017 10:56am EDT 

May 12 (Reuters) - Rui Kang Pharmaceutical Group Investments Ltd <8037.HK>::Vendor entered into disposal agreement with purchaser.consideration for sale shares is HK$4.8 million.Vendor has agreed to dispose of and purchaser has agreed to acquire sale shares at consideration.Target company is New Health Elite International Limited.Following completion of disposal, group will cease to have any interest in target group.It is estimated that group will record a gain of approximately HK$0.05 million as a result of disposal.Purchaser is gold swing enterprises ltd and vendor is unit of co.  Full Article

Rui Kang Pharmaceutical Group Investments says qtrly loss attributable HK$27.9 million
Wednesday, 10 May 2017 08:34am EDT 

May 10 (Reuters) - Rui Kang Pharmaceutical Group Investments Ltd <8037.HK>:Board does not recommend payment of any dividend for three months ended 31 march 2017.Qtrly turnover HK$34.1 million versus HK$16.6 million.Qtrly loss attributable HK$27.9 million versus loss of HK$ 11 million.  Full Article

Rui Kang Pharmaceutical Group Investments announces resignation of CEO
Tuesday, 18 Apr 2017 08:09am EDT 

April 18 (Reuters) - Rui Kang Pharmaceutical Group Investments Ltd <8037.HK>::Chen Miaoping has tendered her resignation as an executive director and CEO.Leung Pak Hou Anson, executive director, will be appointed as chief executive officer of company.  Full Article

Rui Kang Pharmaceutical Group Investments issues profit warning
Monday, 10 Apr 2017 07:52am EDT 

Rui Kang Pharmaceutical Group Investments Ltd <8037.HK> : Group is expected to record a significant loss for three months ended 31 March 2017 .Rui kang pharmaceutical group investments ltd - expected results due to net loss of approximately hk$23.1 million on financial assets.  Full Article

Rui Kang Pharmaceutical Group issues profit warning
Friday, 6 Jan 2017 06:55am EST 

Rui Kang Pharmaceutical Group Investments Limited <8037.HK> : Group is expected to record a significant loss for year ended 31 December 2016 .Rui Kang Pharmaceutical - expected result due to recognition of impairment loss on trade receivables of approximately HK$4.9 million during 2016 year.  Full Article

Rui Kang Pharmaceutical Group Investments updates on disposal agreement
Thursday, 17 Nov 2016 07:15am EST 

Rui Kang Pharmaceutical Group Investments Limited <8037.HK> : Pursuant to deal vendor has agreed to sell sale share and sale loan at cash consideration of hk$10 million . Sale share represents entire issued share capital of allied view international . Vendor, a direct wholly-owned subsidiary of company, and purchaser entered into disposal agreement .Expected that group will record a net loss of approximately HK$574,000 from disposal.  Full Article

Rui Kang Pharmaceutical Group issues profit warning
Monday, 17 Oct 2016 06:21am EDT 

Rui Kang Pharmaceutical Group Investments Limited <8037.HK> : Rui Kang Pharmaceutical Group -Net loss of group for nine months ended 30 September 2016 for continuing operations is expected to increase .Rui Kang Pharmaceutical-Expected result due to net loss of about HK$22.8 million on financial assets at fair value through profit or loss.  Full Article

Rui Kang Pharmaceutical Group Investments' unit enters into agreement with JFA Capital<8037.HK>
Friday, 15 Jul 2016 07:59am EDT 

Rui Kang Pharmaceutical Group Investments Limited <8037.HK>: Pharm-discloseable transaction:acquisition of 4% interest of the target . Deal for consideration of hk$19.4 million . Purchaser, indirect subsidiary of Rui Kang and JFA Capital entered into sp agreement .  Full Article

Rui Kang Pharmaceutical Group Investments issues profit warning<8037.HK>
Monday, 11 Jul 2016 06:35am EDT 

Rui Kang Pharmaceutical Group Investments Limited <8037.HK>: Pharm-profit warning . Group is expected to record a loss for the six months ended 30 June 2016 .Expected loss mainly due to group recorded a significant net loss of approximately hk$13.3 million on financial assets.  Full Article

Rui Kang Pharmaceutical Group Investments says China Wah Yan disposed 14.9 mln shares of co<8037.HK>
Friday, 27 May 2016 09:18am EDT 

Rui Kang Pharmaceutical Group Investments Ltd <8037.HK>: After disposal, company will restore its minimum public float of 25% of total issued share capital . China Wah Yan disposed of 14.9 million shares, about 2.27% of the total issued share capital .  Full Article

More From Around the Web

No consensus analysis data available.